AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
0.1719
+0.0159 (10.19%)
At close: Jul 6, 2026
AccuStem Sciences Employees
AccuStem Sciences had 4 employees as of December 31, 2025. The number of employees increased by 2 or 100.00% compared to the previous year.
Employees
4
Change (1Y)
2
Growth (1Y)
100.00%
Revenue / Employee
n/a
Profits / Employee
-$450,393
Market Cap
2.51M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4 | 2 | 100.00% |
| Dec 31, 2024 | 2 | -1 | -33.33% |
| Dec 31, 2023 | 3 | -1 | -25.00% |
| Dec 31, 2022 | 4 | 0 | - |
| Dec 31, 2021 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CASI Pharmaceuticals | 214 |
| Vaxxinity | 65 |
| Vaccinex | 27 |
| Iterum Therapeutics | 9 |
| America Great Health | 5 |
| Hepion Pharmaceuticals | 2 |
| Bioxytran | 2 |
| Bio-Path Holdings | 1 |
AccuStem Sciences News
- 6 months ago - AccuStem Sciences Announces StemPrintER Pilot Study with National Surgical Adjuvant Breast and Bowel Project (NSABP) - GlobeNewsWire
- 10 months ago - AccuStem Sciences and EmeritusDX Expand Blood-Based Testing Capabilities to Advance Cancer Diagnostics and Treatment Planning - GlobeNewsWire
- 10 months ago - AccuStem Sciences to Present at the Life Sciences Virtual Investor Forum September 18th - GlobeNewsWire
- 1 year ago - AccuStem Sciences, Inc. Announces Chairman Purchase of Shares - GlobeNewsWire
- 1 year ago - AccuStem Sciences, Inc. and EmeritusDX Announce Partnership to Commercialize MSC Test for Lung Cancer Screening - GlobeNewsWire
- 1 year ago - AccuStem Sciences, Inc. Signs Agreement to Access Blood Samples from Lung Cancer Screening Trial to Expedite MSC Commercialization Plan - GlobeNewsWire
- 1 year ago - AccuStem Sciences to Offer its MSC Blood Test to Lung Cancer Screening Programs in the United States - GlobeNewsWire
- 1 year ago - AccuStem Sciences, Inc. Announces Acquisition of Proprietary MSC Lung Cancer Screening Test - GlobeNewsWire